All Stories

  1. Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

    Article • ClinicoEconomics and Outcomes Research, January 2012, Taylor & Francis

    Professor Anders Gustaf Olsson